Jones RJ - Search Results

1

Inhibited apoptosis and drug resistance in acute myeloid leukaemia.

Smith BD, Bambach BJ, Vala MS, Barber JP, Enger C, Brodsky RA, Burke PJ, Gore SD, Jones RJ. Smith BD, et al. Among authors: jones rj. Br J Haematol. 1998 Sep;102(4):1042-9. doi: 10.1046/j.1365-2141.1998.00854.x. Br J Haematol. 1998. PMID: 9734656 Free article.

2

Induction of cutaneous graft-versus-host disease by administration of cyclosporine to patients undergoing autologous bone marrow transplantation for acute myeloid leukemia.

Yeager AM, Vogelsang GB, Jones RJ, Farmer ER, Altomonte V, Hess AD, Santos GW. Yeager AM, et al. Among authors: jones rj. Blood. 1992 Jun 1;79(11):3031-5. Blood. 1992. PMID: 1586747 Free article.

3

Correlation of occult clonogenic leukemia drug sensitivity with relapse after autologous bone marrow transplantation.

Miller CB, Zehnbauer BA, Piantadosi S, Rowley SD, Jones RJ. Miller CB, et al. Among authors: jones rj. Blood. 1991 Aug 15;78(4):1125-31. Blood. 1991. PMID: 1868244 Free article.

4

Effects of the differentiating agent hexamethylene bisacetamide on normal and myelodysplastic hematopoietic progenitors.

Rowinsky EK, Donehower RC, Spivak JL, Burke PJ, Griffin CA, Jones RJ. Rowinsky EK, et al. Among authors: jones rj. J Natl Cancer Inst. 1990 Dec 19;82(24):1926-31. doi: 10.1093/jnci/82.24.1926. J Natl Cancer Inst. 1990. PMID: 2250314

5

Bryostatin 1, a unique biologic response modifier: anti-leukemic activity in vitro.

Jones RJ, Sharkis SJ, Miller CB, Rowinsky EK, Burke PJ, May WS. Jones RJ, et al. Blood. 1990 Mar 15;75(6):1319-23. Blood. 1990. PMID: 2310830 Free article.

6

In vitro evaluation of combination drug purging for autologous bone marrow transplantation.

Jones RJ, Miller CB, Zehnbauer BA, Rowley SD, Colvin OM, Sensenbrenner LL. Jones RJ, et al. Bone Marrow Transplant. 1990 May;5(5):301-7. Bone Marrow Transplant. 1990. PMID: 2350626

7

BCR-ABL-mediated inhibition of apoptosis with delay of G2/M transition after DNA damage: a mechanism of resistance to multiple anticancer agents.

Bedi A, Barber JP, Bedi GC, el-Deiry WS, Sidransky D, Vala MS, Akhtar AJ, Hilton J, Jones RJ. Bedi A, et al. Among authors: jones rj. Blood. 1995 Aug 1;86(3):1148-58. Blood. 1995. PMID: 7620167 Free article.

8

Inhibition of apoptosis during development of colorectal cancer.

Bedi A, Pasricha PJ, Akhtar AJ, Barber JP, Bedi GC, Giardiello FM, Zehnbauer BA, Hamilton SR, Jones RJ. Bedi A, et al. Among authors: jones rj. Cancer Res. 1995 May 1;55(9):1811-6. Cancer Res. 1995. PMID: 7728743

9

Assessment of aldehyde dehydrogenase in viable cells.

Jones RJ, Barber JP, Vala MS, Collector MI, Kaufmann SH, Ludeman SM, Colvin OM, Hilton J. Jones RJ, et al. Blood. 1995 May 15;85(10):2742-6. Blood. 1995. PMID: 7742535 Free article.

10

Cytotoxic T cells overcome BCR-ABL-mediated resistance to apoptosis.

Fuchs EJ, Bedi A, Jones RJ, Hess AD. Fuchs EJ, et al. Among authors: jones rj. Cancer Res. 1995 Feb 1;55(3):463-6. Cancer Res. 1995. PMID: 7834607

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

758 results

Search Page

Filters